Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Merchant Website

Melinda S. Merchant, M.D., Ph.D.

Selected Publications

1)  Grady C, Wiener L, Abdoler E, Trauernicht E, Zadeh S, Diekema DS, Wilfond BS, Wendler D.
Assent in research: the voices of adolescents.
J Adolesc Health. 54: 515-20, 2014.
2)  Martin S, Wolters PL, Baldwin A, Roderick MC, Toledo-Tamula MA, Gillespie A, Widemann B.
Attitudes About Internet Support Groups Among Adolescents and Young Adults with Neurofibromatosis Type 1 and their Parents.
J Genet Couns. [Epub ahead of print], 2014.
3)  Wiener L, Baird K, Crum C, Powers K, Carpenter P, Baker KS, MacMillan ML, Nemecek E, Lai JS, Mitchell SA, Jacobsohn DA.
Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.
Support Care Cancer. 22: 295-305, 2014.
4)  Zadeh S, Pao M, Wiener L.
Opening end-of-life discussions: How to introduce Voicing My CHOiCES™, an advance care planning guide for adolescents and young adults.
Palliat Support Care. 1-9, 2014.
5)  Wiener L, Viola A, Koretski J, Perper ED, Patenaude AF.
Pediatric psycho-oncology care: standards, guidelines, and consensus reports.
Psychooncology. [Epub ahead of print], 2014.
6)  Widemann BC, Dombi E, Gillespie A, Wolters PL, Belasco J, Goldman S, Korf BR, Solomon J, Martin S, Salzer W, Fox E, Patronas N, Kieran MW, Perentesis JP, Reddy A, Wright JJ, Kim A, Steinberg SM, Balis FM.
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
Neuro-oncology. 16: 707-18, 2014.
7)  Widemann BC, Babovic-Vuksanovic D, Dombi E, Wolters PL, Goldman S, Martin S, Goodwin A, Goodspeed W, Kieran MW, Cohen B, Blaney SM, King A, Solomon J, Patronas N, Balis FM, Fox E, Steinberg SM, Packer RJ.
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
Pediatr Blood Cancer. 61: 1598-602, 2014.
8)  Wiener L, Sweeney C, Baird K, Merchant MS, Warren KE, Corner GW, Roberts KE, Lichtenthal WG.
What do parents want to know when considering autopsy for their child with cancer?.
J. Pediatr. Hematol. Oncol. 36: 464-70, 2014.
9)  Plotkin SR, Blakeley JO, Dombi E, Fisher MJ, Hanemann CO, Walsh KS, Wolters PL, Widemann BC.
Achieving consensus for clinical trials: the REiNS International Collaboration.
Neurology. 81: S1-5, 2013.
10)  Hensler MA, Katz ER, Wiener L, Berkow R, Madan-Swain A.
Benefit finding in fathers of childhood cancer survivors: a retrospective pilot study.
J Pediatr Oncol Nurs. 30: 161-8, 2013.
11)  Jones P, Blunda M, Biegel G, Carlson LE, Biel M, Wiener L.
Can mindfulness-based interventions help adolescents with cancer?.
Psychooncology. 22: 2148-51, 2013.
12)  Widemann BC, Blakeley JO, Dombi E, Fisher MJ, Hanemann CO, Walsh KS, Wolters PL, Plotkin SR.
Conclusions and future directions for the REiNS International Collaboration.
Neurology. 81: S41-4, 2013.
13)  Wiener L, McConnell DG, Latella L, Ludi E.
Cultural and religious considerations in pediatric palliative care.
Palliat Support Care. 11: 47-67, 2013.
14)  van Den Brink M, Leen AM, Baird K, Merchant M, Mackall C, Bollard CM.
Enhancing immune reconstitution: from bench to bedside.
Biol. Blood Marrow Transplant. 19: S79-83, 2013.
15)  Margolis R, Ludi E, Pao M, Wiener L.
International adaptation: psychosocial and parenting experiences of caregivers who travel to the United States to obtain acute medical care for their seriously ill child.
Soc Work Health Care. 52: 669-83, 2013.
16)  Martin S, Wolters P, Billings N, Toledo-Tamula MA, Hammoud DA, Welch P, Darnell D, Holland SM, Freeman AF.
Neurobehavioral Profiles in Individuals with Hyperimmunoglobulin E Syndrome (HIES) and Brain White Matter Hyperintensities.
J. Clin. Immunol. 33: 1175-84, 2013.
17)  Wolters PL, Martin S, Merker VL, Gardner KL, Hingtgen CM, Tonsgard JH, Schorry EK, Baldwin A.
Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.
Neurology. 81: S6-14, 2013.
18)  Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Reddy A, Korf B, Widemann BC.
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.
Pediatr Blood Cancer. 60: 396-401, 2013.
19)  Magnan H, Abramson SJ, Price AP, Grewal RK, Merchant MS, LaQuaglia MP, Meyers PA.
Positron emission tomography for response assessment in desmoplastic small round cell tumor.
J. Pediatr. Hematol. Oncol. 35: e190-3, 2013.
20)  Fair C, Wiener L, Zadeh S, Albright J, Mellins CA, Mancilla M, Tepper V, Trexler C, Purdy J, Osherow J, Lovelace S, Kapetanovic S.
Reproductive health decision-making in perinatally HIV-infected adolescents and young adults.
Matern Child Health J. 17: 797-808, 2013.
21)  Pao M, Wiener L, Zadeh S.
Talking with patients about dying.
N. Engl. J. Med. 368: 480, 2013.
22)  Wiener L, Zadeh S, Wexler LH, Pao M.
When silence is not golden: Engaging adolescents and young adults in discussions around end-of-life care choices.
Pediatr Blood Cancer. 60: 715-8, 2013.
23)  Warren K, Bent R, Wolters PL, Prager A, Hanson R, Packer R, Shih J, Camphausen K.
A phase 2 study of pegylated interferon a-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma.
Cancer. 118: 3607-13, 2012.
24)  Wiener L, Oppenheim D, Breyer J, Battles H, Zadeh S, Patenaude AF.
A worldview of the professional experiences and training needs of pediatric psycho-oncologists.
Psychooncology. 21: 944-53, 2012.
25)  Wiener L, Zadeh S, Battles H, Baird K, Ballard E, Osherow J, Pao M.
Allowing adolescents and young adults to plan their end-of-life care.
Pediatrics. 130: 897-905, 2012.
26)  Calabrese SK, Martin S, Wolters PL, Toledo-Tamula MA, Brennan TL, Wood LV.
Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents.
AIDS Care. 24: 1092-6, 2012.
27)  Martin S, Calabrese SK, Wolters PL, Walker KA, Warren K, Hazra R.
Family functioning and coping styles in families of children with cancer and HIV disease.
Clin Pediatr (Phila). 51: 58-64, 2012.
28)  Wiener L, Battles H, Zadeh S, Smith CJ, Helman LJ, Kim SY.
Gastrointestinal stromal tumor: psychosocial characteristics and considerations.
Support Care Cancer. 20: 1343-9, 2012.
29)  Phipps S, Buckholdt KE, Fernandez L, Wiener L, Kupst MJ, Madan-Swain A, Mullins L, Robert R, Sahler OJ, Vincent N, Noll RB.
Pediatric oncologists" practices of prescribing selective serotonin reuptake inhibitors (SSRIs) for children and adolescents with cancer: a multi-site study.
Pediatr Blood Cancer. 58: 210-5, 2012.
30)  Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL.
Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.
J. Clin. Oncol. 30: 4141-7, 2012.
31)  Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, Widemann B.
Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables.
J Pediatr Psychol. 37: 713-24, 2012.
32)  Zadeh S, Gamba N, Hudson C, Wiener L.
Taking care of care providers: a wellness program for pediatric nurses.
J Pediatr Oncol Nurs. 29: 294-9, 2012.
33)  Wiener L, Crum C, Grady C, Merchant M.
To friend or not to friend: the use of social media in clinical oncology.
J Oncol Pract. 8: 103-6, 2012.
34)  Wendler D, Abdoler E, Wiener L, Grady C.
Views of adolescents and parents on pediatric research without the potential for clinical benefit.
Pediatrics. 130: 692-9, 2012.
35)  Merchant MS.
Chaperoning the lympho-stromal dance.
Blood. 115: 2334-5, 2010.
36)  Merchant MS, Mackall CL.
Current approach to pediatric soft tissue sarcomas.
Oncologist. 14: 1139-53, 2009.
37)  Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Hennighausen L, Kurtulus S, Erman B, Matzinger P, Merchant MS, Mackall CL.
Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.
Nat. Immunol. 10: 149-57, 2009.
38)  Casey DA, Wexler LH, Merchant MS, Chou AJ, Merola PR, Price AP, Meyers PA.
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
Pediatr Blood Cancer. 53: 1029-34, 2009.
39)  Merchant MS.
Long-term impact of cancer care on activities of daily living: are we causing our sarcoma survivors to grow up too quickly?.
Pediatr Blood Cancer. 53: 531-2, 2009.
40)  Merchant MS, Melchionda F, Sinha M, Khanna C, Helman L, Mackall CL.
Immune reconstitution prevents metastatic recurrence of murine osteosarcoma.
Cancer Immunol. Immunother. 56: 1037-46, 2007.
41)  Merchant MS, Yang X, Melchionda F, Romero M, Klein R, Thiele CJ, Tsokos M, Kontny HU, Mackall CL.
Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing"s sarcoma.
Cancer Res. 64: 8349-56, 2004.
Click Here to View Collapsed Bibliography.

This page was last updated on 7/31/2014.